Research prototype, not medical advice.

RTB101 was positive in phase 2b, but phase 3 missed its primary endpoint (clinically symptomatic respiratory infections).

Confidence
Debated
Level of evidence
Randomized clinical trial
Observed in
Human
Mission
Map of aging (12 hallmarks)
Concepts
Deregulated nutrient sensingRTB101 (dactolisib)mTOR (mTORC1)

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials
Mannick et al. · The Lancet Healthy Longevity 2021
— Verified

Related claims